Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients
NCT06424808 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-05-22
Summary
The investigators aim to evaluate the improvement of the inpatient experience and the usability of a content-based tool (a brochure). This involves consolidating video content for inpatients on a single website and providing access to it via QR codes in a brochure format.
\[Patients\] Considering this as a pilot study, the investigators plan to recruit around 30 participants. Both the experimental and control groups will receive standard care and information, with the experimental group additionally receiving the brochure. Random assignment will be used for the experimental and control groups. Surveys and interviews will be conducted to assess changes in patient experience and usability before and after providing the brochure.
\[Medical Staff\] Among the medical staff involved in the liver transplant surgical process, researchers will select participants based on their degree of involvement with the intervention subjects. After obtaining their consent, interviews will be conducted concerning patient experiences and the brochure.
Conditions
- Liver Transplantation
- Inpatients
Interventions
- OTHER
-
Consolidating content on a single website and providing access to it via QR codes in a brochure format
The group assigned to the experimental group will receive information in the same manner as current patients do, with the addition of receiving a brochure once when moving to a general ward after surgery. Afterward, they are free to use the brochure. The control group will receive information only in the manner currently provided to patients.
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-21
- Primary Completion
- 2024-10-31
- Completion
- 2024-11-30
More Related Trials
-
Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure
NCT06996392 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients
NCT03882346 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study of the Liver Live Donor Champion Program
NCT03580629 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis
NCT06533852 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Fecal Microbiota Transplantation for Decompensated Cirrhosis
NCT03014505 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis
NCT06306781 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial of Faecal Microbiota Transplantation in Cirrhosis
NCT02862249 ·Status: COMPLETED ·Phase: PHASE3
-
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01483248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
NCT01707849 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
NCT03193151 ·Status: RECRUITING
-
Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.
NCT03930459 ·Status: TERMINATED ·Phase: NA
-
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.
NCT02721264 ·Status: UNKNOWN ·Phase: NA
-
Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis
NCT03209986 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.
NCT02868164 ·Status: WITHDRAWN ·Phase: NA
-
Hepatocyte Transplantation for Acute Decompensated Liver Failure
NCT01345565 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Synbiotic on Postoperative Complications After Liver Transplantation
NCT02938871 ·Status: UNKNOWN ·Phase: NA
-
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
NCT01073202 ·Status: COMPLETED ·Phase: NA
-
Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis
NCT01412593 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1
-
Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
NCT03468140 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Faecal Microbiota Transplantation for Liver Cirrhosis
NCT04932577 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients
NCT01718587 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis
NCT03803540 ·Status: UNKNOWN ·Phase: PHASE1
-
To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis
NCT06296095 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
NCT05985863 ·Status: RECRUITING ·Phase: PHASE1/PHASE2